We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
We sent a memo to the members of the boards of pharmacy of every state, calling out just about every bit of nonsense being spewed by … well, you know ...
Our CEO’s op-ed in Inside Sources’ DC Journal hits back against the tiresome litany of drugmaker accusations against pharmacy compounding.
Our latest webinar is all about how to create the right indicators so you’ve got real, actionable data points to set goals and measure performance.
What would you think of a compounding-focused “boutique” wholesaler as a benefit for our Pharmacy/Facility Members?
The FDA is finally removing an infamous (and infamously flawed) boxed warning from HRT products ... and that bodes well.
.png?width=410&height=320&name=image-container%20(1).png)
.png?width=410&height=320&name=image-container%20(2).png)
.png?width=411&height=320&name=image-container%20(3).png)
.png?width=410&height=320&name=image-container%20(4).png)
.png)
.png?width=17&height=16&name=folder%20(1).png){kind=small}
%20Pharma-GS.png)
.jpg?width=1456&height=180&name=InformaConnect%20CompoundingYearEnd_728x90_A4PC%20(002).jpg)
